A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
一项 II 期随机安慰剂对照双盲研究，比较挽救性放射治疗加安慰剂与 SRT 加恩扎卢胺治疗根治性前列腺切除术后高危 PSA 复发性前列腺癌的疗效 (SALV-ENZA)
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-019-5805-z
Kapoor, Roche; Deek, Matthew P; McIntyre, Riley; Raman, Natasha; Kummerlowe, Megan; Chen, Iyah; Gaver, Matt; Wang, Hao; Denmeade, Sam; Lotan, Tamara; Paller, Channing; Markowski, Mark; Carducci, Michael; Eisenberger, Mario; Beer, Tomasz M; Song, Daniel Y; DeWeese, Theodore L; Hearn, Jason W; Greco, Stephen; DeVille, Curtiland; Desai, Neil B; Heath, Elisabeth I; Liauw, Stanley; Spratt, Daniel E; Hung, Arthur Y; Antonarakis, Emmanuel S; Tran, Phuoc T
